ArticleJAMA network open2025
Spending Changes After Moving to Areas With Greater ACO Participation Among Nonattributed Medicare Beneficiaries.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Importance: Accountable care organizations (ACOs) under the Medicare Shared Savings Program have long been envisioned as a pathway to improved care efficiency and quality of care for all Medicare beneficiaries. However, little is known about whether the changes in health care spending associated with ACOs have extended beyond ACO-attributed Medicare beneficiaries to all Medicare beneficiaries. Objective: To estimate spending changes by non-ACO-attributed Medicare beneficiaries after moving to geographic areas with greater ACO participation. Design, Setting, and Participants: This repeated cross-sectional study analyzed claims from a 20% representative sample of all Medicare beneficiaries, aged 65 to 99 years, from 2009 to 2017. The sample consisted of Medicare beneficiaries who were never attributed to an ACO and moved once across hospital service areas (HSAs) during the study period (movers) and was supplemented by a 20% random sample of beneficiaries who never moved (nonmovers). Data analysis took place from November 2022 to October 2024. Exposure: Changes in the ACO market penetration rate triggered by nonattributed Medicare beneficiaries moving across HSAs. Main Outcomes and Measures: Annual standardized Medicare spending per beneficiary on acute inpatient, outpatient facility, physician services, and total acute care as well as on hospital outpatient department, evaluation and management, and nonadmitted emergency department visits. Results: The estimation sample included 62 618 movers (388 263 beneficiary-years; mean [SD] age, 75 [7] years; 134 503 [65%] female-years) and 433 298 nonmovers (2 066 404 beneficiary-years; mean [SD] age, 76 [8] years; 1 273 154 [62%] female-years). In the base model, moving into a market with a 1-SD higher ACO penetration was associated with a 5.8% (95% CI, 4.1%-7.4%) decrease in spending on outpatient facilities and with a 1.6% (95% CI, 0.9% to 2.2%) increase in spending on physician services. Limited changes in total spending on acute inpatient and total acute care were found. These estimated changes were robust to controlling for a rich set of patient- and market-level characteristics and origin-destination HSA combinations. Conclusions and Relevance: This study provided novel evidence of market-level ACO spillovers to non-ACO-attributed Medicare beneficiaries. Although no substantial ACO spillovers in total acute care spending occurred, the substitution in spending on outpatient facility and physician services suggested that outpatient care may shift away from higher-cost facility settings for all Medicare beneficiaries in markets with greater ACO penetration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.